clevelanddx.comHealthcare / BioTech & PharmaFounded: 2013
Cleveland Diagnostics, Inc. is a clinical-stage biotechnology company that focuses on developing next-generation innovative diagnostic tests for the early detection of various diseases, with a particular emphasis on cancer.Cleveland Diagnostics introduces a new category of straightforward blood tests designed to detect the presence or absence of diseases. Their flagship product, IsoPSA, addresses the urgent need for a more concise method to help avoid unnecessary prostate biopsies. Leveraging its unique SIA-based technology platform, Cleveland Diagnostics aims to transform cancer diagnosis into a less daunting prospect. The company facilitates prompt and potentially lifesaving medical decisions by providing physicians and patients with more accurate cancer insights at earlier stages.
View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like ClevelandDx.
Become part of the Secondary Marketplace, catering to both individual and institutional investors.